excoriator
Madrigal Member 
nearly a genius
Posts: 37,165
|
Post by excoriator on Dec 2, 2020 13:49:37 GMT
The health sec. was described as being thrilled at the licensing for use of a covid-19, but I cannot imagine normal guilty hangdog expression ever looking 'thrilled', although I suppose its possible.
Will we get a choice of what vaccine we'll get? I know at the moment there is only that can be used, but by the time I'm allowed a shot, there may be more than one.
|
|
|
|
Post by aubrey on Dec 2, 2020 16:46:20 GMT
He was grinning like a loon on TV this morning.
|
|
jonjel
Madrigal Member
Posts: 3,931
|
Post by jonjel on Dec 3, 2020 11:40:28 GMT
The health sec. was described as being thrilled at the licensing for use of a covid-19, but I cannot imagine normal guilty hangdog expression ever looking 'thrilled', although I suppose its possible. Will we get a choice of what vaccine we'll get? I know at the moment there is only that can be used, but by the time I'm allowed a shot, there may be more than one. I doubt you will be given the choice Exco, but all of them seem to be effective. People are saying of the Oxford vaccine 'ahh, but only 70% effective' Well the common flu vaccine is only 50% effective and most people don't bat an eyelid and have the flu jab when it is offered. I have little doubt the Oxford one will be approved within a very short timeframe, 10 days or so. It will be far easier to distribute than the Pfizer one. And as an aside I was with some of the Oxford group yesterday dropping off 'stuff' for them and the mood can only be described as euphoric. These people have been working incredibly long hours sometimes 7 days a week and all credit to them. |
|
|
|
Post by skylark on Dec 4, 2020 10:52:26 GMT
The 70% figure for the Oxford vaccine is an average only. The initial trials, when volunteers were given two full doses, resulted in a success rate of 62%. Then an error happened, and it was discovered that a batch of volunteers were getting a half dose followed by a full dose, and this resulted in a success rate of (at least) 90%. Now, the 'mistake' dose had too small small a sample to be approved, so will everyone hold fire until a more complete stage three trial of this regime can be carried out and evaluated? We don't know.
|
|
